News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
318,987 Results
Type
Article (18604)
Company Profile (122)
Press Release (300261)
Section
Business (91580)
Career Advice (753)
Deals (14601)
Drug Delivery (40)
Drug Development (49301)
Employer Resources (47)
FDA (7512)
Job Trends (7189)
News (162978)
Policy (14168)
Tag
Academia (1628)
Alliances (22261)
Alzheimer's disease (913)
Approvals (7482)
Artificial intelligence (54)
Bankruptcy (146)
Best Places to Work (6152)
Biotechnology (100)
Breast cancer (70)
Cancer (607)
Cardiovascular disease (57)
Career advice (633)
Cell therapy (140)
Clinical research (38940)
Collaboration (198)
Compensation (80)
COVID-19 (1241)
C-suite (53)
Cystic fibrosis (47)
Data (723)
Diabetes (99)
Diagnostics (2783)
Earnings (35276)
Events (51101)
Executive appointments (162)
FDA (7801)
Funding (178)
Gene therapy (113)
GLP-1 (332)
Government (2131)
Healthcare (8914)
Infectious disease (1290)
Inflammatory bowel disease (62)
Interviews (94)
IPO (7338)
Job creations (1278)
Job search strategy (585)
Layoffs (129)
Legal (2633)
Lung cancer (80)
Manufacturing (80)
Medical device (4995)
Medtech (4996)
Mergers & acquisitions (7313)
Metabolic disorders (250)
Neuroscience (1066)
NextGen Class of 2024 (2893)
Non-profit (2181)
Northern California (928)
Obesity (131)
Opinion (87)
Patents (52)
People (28584)
Phase I (12161)
Phase II (17559)
Phase III (12498)
Pipeline (293)
Postmarket research (1496)
Preclinical (5580)
Press Release (52)
Radiopharmaceuticals (131)
Rare diseases (109)
Real estate (2276)
Regulatory (10047)
Research institute (1232)
Resumes & cover letters (116)
Southern California (807)
Startups (1743)
United States (7342)
Vaccines (229)
Weight loss (77)
Date
Today (108)
Last 7 days (615)
Last 30 days (2165)
Last 365 days (20395)
2024 (18443)
2023 (22626)
2022 (27709)
2021 (29875)
2020 (27044)
2019 (22137)
2018 (16828)
2017 (16057)
2016 (14962)
2015 (17796)
2014 (12882)
2013 (10098)
2012 (11051)
2011 (11704)
2010 (10529)
Location
Africa (324)
Arizona (47)
Asia (17255)
Australia (3695)
California (1983)
Canada (697)
China (122)
Colorado (60)
Connecticut (86)
Europe (41220)
Florida (221)
Georgia (50)
Illinois (191)
Indiana (111)
Kansas (64)
Maryland (261)
Massachusetts (1336)
Michigan (87)
Minnesota (131)
New Jersey (583)
New York (557)
North Carolina (395)
Northern California (928)
Ohio (70)
Pennsylvania (451)
South America (467)
Southern California (807)
Texas (230)
Washington State (274)
318,987 Results for "virginia biotechnology association vabio".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Business
Scailyte Announces Virginia Savova, PhD as a Strategic and Scientific Advisor
Scailyte, a biomarker discovery company leveraging single-cell omics and artificial intelligence, proudly announces the appointment of Virginia Savova, PhD as a strategic and scientific advisor.
June 14, 2024
·
2 min read
Drug Development
Kiromic BioPharma Adds Virginia Oncology Associates, PC as the Second Clinical Trial Site in the Ongoing Phase 1 Deltacel-01 Trial
Kiromic BioPharma, Inc. (OTCQB: KRBP) (“Kiromic” or the “Company”) announces that Virginia Oncology Associates, PC (Norfolk, Virginia) has been activated as the second clinical trial site in the Phase 1 Deltacel-01 trial evaluating Deltacel™ (KB-GDT-01), Kiromic’s allogeneic, off-the-shelf, Gamma Delta T-cell (GDT) therapy, in patients with non-small cell lung cancer (NSCLC).
March 1, 2024
·
5 min read
Business
Virginia Oncology Associates Chooses the Ivenix Infusion System from Fresenius Kabi
Fresenius Kabi announced today it has signed an agreement with Virginia Oncology Associates (VOA) under which VOA will purchase the Ivenix Infusion System to deliver medications for its patients.
September 14, 2023
·
3 min read
Press Releases
University of Virginia Researchers Publish New Study on Tropomyosin Proteoforms Showcasing Quantum-Si’s Next-Gen Protein Sequencer™ Platinum®
November 8, 2024
·
2 min read
Pharm Country
West Virginia University Health System Selects Imagine Pharma to Provide Human Islet Isolation Services for Autologous Clinical Transplantation
Imagine Pharma, a biotech company focused on advancing the commercialization of its novel IMG-1 polypeptide in Oral Delivery, Therapeutics, and Regenerative Medicine, announced that the West Virginia University Health System, which operates under the brand WVU Medicine, has awarded a contract to the Company to provide human clinical islet isolation services for patients undergoing a total pancreatectomy and autologous islet cell transplant.
May 28, 2024
·
3 min read
Press Releases
More States Join the Movement: The Nerivio® REN Wearable Now Covered by Arizona, New Jersey, Ohio, and Virginia Medicaid Programs
October 1, 2024
·
5 min read
Business
Empress Therapeutics Appoints Virginia Finnerty-Brooks Chief Business Officer
Empress Therapeutics today announced that Virginia Finnerty-Brooks has been appointed Chief Business Officer (CBO).
December 6, 2023
·
3 min read
Business
ATCC Receives Grant from Commonwealth’s Development Opportunity Fund to Apply Toward Its New Biomanufacturing Suite in Virginia
September 12, 2024
·
3 min read
Business
Xenetic Biosciences, Inc. Enters into Research Agreement with the University of Virginia for the Advancement of its DNase-Based Oncology Platform
Xenetic Biosciences, Inc. today announced it has entered into a Research Funding Agreement and a Material Transfer Agreement with the University of Virginia (“UVA”) to advance the development of its systemic DNase program.
January 17, 2024
·
6 min read
Press Releases
Carilion Clinic further expands quality cardiac care access with latest Philips innovations at new regional cardiovascular institute in Virginia, US
August 21, 2024
·
5 min read
1 of 31,899
Next